Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-06-14
2005-06-14
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C436S501000
Reexamination Certificate
active
06905833
ABSTRACT:
Methods and kits for detecting breast cancer or a high risk of breast cancer by measuring bFGF in nipple fluid from subjects compare the levels of bFGF in samples from test subjects with the levels of bFGF in subjects not having breast cancer, where increased levels of bFGF in test subjects indicate the presence of breast cancer, or a high risk of breast cancer, in the test subjects.
REFERENCES:
patent: 5187062 (1993-02-01), Sato et al.
Sauter et al., Br J Cancer. Dec. 1999;81(7):1222-7.
Products for Life Sciences Research (200-2001 Sigma Catalog, p. 979 only).
Nguyen, 1997, Investigational New Drugs, 15:29-37.
Relf, et al., 1997, Cancer Research, 57(5):963-3.
Li, et al 1994, The Lancet, 344: 82-86.
Cheales-Siebenaler, et al., 1999, Journal of Human Lactation, 15(1):41-3.
Cheales-Siebenaler, Noreen J., “Induced Lactation in an Adoptive Mother,”Journal of Human Lactation, Mar. 1999, 15(1):41-3. (Exhibit 2).
Foretova, Lenka et al., “Carcinembryonic Antigen in Breast Nipple Aspirate Fluid,”Cancer Epidemiology, Biomarkers and Prevention, Mar. 1998, 7:195-8. (Exhibit 3).
Fujimoto, Kiyohide et al., “Increased Serum Levels of Basic Fibrolast Growth Factor in Patients with Renal Cell Carcinoma,”Biochemical and Biophysical and Research Communications, Oct. 15, 1991, 180(1):386-92. (Exhibit 4).
Gail, Mitchell H. et al., “Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually,”Journal of the National Cancer Institute, Dec. 20, 1989, 81(24):1879-86. (Exhibit 5).
Gann, Peter et al., “Mitogenic Growth Factors in Breast Fluid Obtained from Healthy Women: Evaluation of Biological and Extraneous Sources of Variability,”Cancer Epidemiology, Biomarkers and Prevention, Jun. 1997, 6(6):421-8. (Exhibit 6).
Li, Vincent W. et al., “Microvessel Count and Cerebrospinal Fluid Basic Fibroblast Growth Factor In Chidren With Brain Tumours,”Lancet, Jul. 9, 1994, 344:82-6. (Exhibit 7).
Lin, Richard Y. et al., “Diagnostic and Prognostic Role of Basic Fibroblast Growth Factor In Wilms' Tumor Patients,”Clinical Cancer Research, Mar. 1995, 1:327-31. (Exhibit 8).
Nguyen, Mai, “Angiogenic Factors as Tumor Markers,”Investigational New Drugs, 1997, 15:29-37. (Exhibit 9).
Nguyen, Mai et al., “Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients with a Wide Spectrum of Cancers,”Journal of National Cancer Institute, Mar. 2, 1994, 86(5):356-61. (Exhibit 10).
O'Brien, T.S. et al., “Urinary Basic Fibroblast Growth Factor in Patients with Bladder Cancer and Benign Prostatic Hypertrophy,”British Journal of Urology, 1995, 76:311-4. (Exhibit 11).
Petrakis, Nicholas L., “Nipple Aspirate Fluid in Epidemiologic Studies of Breast Disease,”Epidemiologic Reviews, 1993, 15(1):188-95. (Exhibit 12).
Rose, David P., “Hormones and Growth Factors in Nipple Aspirates from Normal Women and Benign Breast Disease Patients,”Cancer Detection and Prevention, 1992, 16(1):43-51. (Exhibit 13).
Sauter, Edward R. et al., “Prostate-Specific Antigen Levels in Nipple Aspirate Fluid Correlate with Breast Cancer Risk,”Cancer Epidemiology, Biomarkers and Prevention, Dec. 1996, 5:967-70. (Exhibit 14).
Sluitz, G. et al., “Serum Evaluation of Basic Fibroblast Growth Factor in Cervical Cancer Patients,”Cancer Letters, 1995, 94(2):227-31. (Exhibit 15).
Takei, Yoshifumi et al., “Serum Concentrations of Basic Fibroblast Growth Factor in Breast Cancer,”Clinical Chemistry, 1994, 40(10):1980-1. (Exhibit 16).
Watanabe, H. et al., (Abstract) “Basic Fibroblast Growth Factor in Human Serum—A Prognostic Test for Breast Cancer,”Molecular Biology of the Cell(formerly Cell Regulation)Abstracts, Sep. 1992, 3:234a. (Exhibit 17).
Watanabe, Hiroyuki et al., “A Sensitive Enzyme Immunoassay for Human Basic Fibroblast Growth Factor,”Biochemical and Biophysical Research Communications, Feb. 28, 1991, 175(1):229-35. (Exhibit 18).
Wrensch, Margaret et al., “Breast Cancer Risk Associated with Abnormal Cytology in Nipple Aspirates of Breast Fluid and Prior History of Breast Biopsy,”American Journal of Epidemiology, Apr. 15, 1993, 137(8):829-33. (Exhibit 19).
Wrensch, Margaret R. et al., “Factors Associated with Obtaining Nipple Aspirate Fluid: Analysis of 1428 Women and Literative Review,”Breast Cancer Research and Treatment, 1990, 15:39-51. (Exhibit 20).
Liu, Yeheng et al., “Breast-Cancer Diagnosis with Nipple Fluid bFGF,”The Lancet, Aug. 12, 2000, 356(9229):567. (Exhibit 21).
Reilly, Thomas M. et al., “Monoclonal Antibodies Directed Against Basic Fibroblast Growth Factor Which Inhibits Its Biological Activity In Vitro and in Vivo,”Biochemical and Biophysical Research Communications, Oct. 30, 1989, 164(2):736-43. (Exhibit 22).
Helms Larry R.
Smith , Gambrell & Russell, LLP
Sundby Suzannah K.
The Regents of the University of California
Yu Misook
LandOfFree
Method of diagnosing breast cancer using nipple fluid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing breast cancer using nipple fluid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing breast cancer using nipple fluid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512528